TG4010 added to chemotherapy vs chemotherapy alone
Adverse effects: at least one serious adverse event · People with advanced non‐small cell lung cancer
It is very uncertain whether TG4010 added to chemotherapy changes participants with at least one serious adverse event compared with chemotherapy alone (very low certainty).
1 finding from 1 review
- RR 0.7 [0.23, 2.19]2 studies · 362 participantsVery low